As we summarized in our review,26 abnormal CRKL expression is associated with HCC, RCC, gastric cancer, glioblastoma multiforme, bladder cancer, lung cancer, colon cancer, ovarian cancer, leukaemia, breast cancer, head and neck cancer, rhabdomyosarcoma and neuroblastoma. This evidence concerns the gene CRKL and glioblastoma.